Growing epidemic of coronary heart disease in low- and middle-income countries.
暂无分享,去创建一个
Asaf Bitton | Adrianna Murphy | A. Murphy | A. Bitton | S. Anand | T. Gaziano | S. Abrahams-Gessel | Thomas A Gaziano | Shuchi Anand | Shafika Abrahams-Gessel
[1] R Laurenti,et al. Ischemic heart disease. Hospitalization, length of stay and expenses in Brazil from 1993 to 1997. , 2000, Arquivos brasileiros de cardiologia.
[2] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[3] J. Rossouw,et al. Community-based intervention: the Coronary Risk Factor Study (CORIS). , 1993, International journal of epidemiology.
[4] Alan D. Lopez,et al. Global burden of disease and risk factors , 2006 .
[5] B. Popkin,et al. The nutrition transition: worldwide obesity dynamics and their determinants , 2004, International Journal of Obesity.
[6] C. la Vecchia,et al. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000 , 2005, Heart.
[7] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[8] E. Poskitt. Countries in transition: underweight to obesity non-stop? , 2009, Annals of tropical paediatrics.
[9] Milton C. Weinstein,et al. Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.
[10] S. Olshansky,et al. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. , 1986, The Milbank quarterly.
[11] A. Mansur,et al. Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. , 2001, Arquivos brasileiros de cardiologia.
[12] B. Popkin,et al. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. , 2009, Nutrition reviews.
[13] Dean T. Jamison,et al. Measuring the Global Burden of Disease and Risk Factors, 1990–2001 , 2006 .
[14] R. Collins,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[15] Jesús Santos,et al. Peripheral arterial disease in HIV patients older than 50 years of age. , 2008, AIDS research and human retroviruses.
[16] Rajeev Gupta. Burden of coronary heart disease in India. , 2005, Indian heart journal.
[17] Rafael Emidio da Silva,et al. Viable myocardium scintigraphy with intravenous nitroglycerine by computed tomography with Tc-99m (MIBI). , 2008, Arquivos brasileiros de cardiologia.
[18] H. Ong,et al. β blockers in hypertension and cardiovascular disease , 2007, BMJ : British Medical Journal.
[19] R. Veras,et al. The decline in mortality from circulatory diseases in Brazil. , 2009, Revista panamericana de salud publica = Pan American journal of public health.
[20] Alan D. Lopez,et al. Role of Smoking in Global and Regional Cardiovascular Mortality , 2005, Circulation.
[21] D. Kromhout,et al. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. , 2006, European heart journal.
[22] K. Reddy,et al. Cardiovascular disease in non-Western countries. , 2004, The New England journal of medicine.
[23] S. Kachboura,et al. [The first Tunisian cardiovascular diseases register: processes and results]. , 2004, Revue d'epidemiologie et de sante publique.
[24] Alan D. Lopez,et al. Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India , 2009, Circulation.
[25] Eric Boerwinkle,et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. , 2006, Archives of internal medicine.
[26] Stanton A Glantz,et al. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study , 2004, BMJ : British Medical Journal.
[27] C. Seale. Changing patterns of death and dying. , 2000, Social science & medicine.
[28] S. Mendis,et al. Prevention of cardiovascular disease in developing countries , 2007, The Lancet.
[29] Alan D. Lopez,et al. Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.
[30] E. C. Moura,et al. Socioeconomic status and obesity in adult populations of developing countries: a review. , 2004, Bulletin of the World Health Organization.
[31] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[32] B. Popkin,et al. Overweight exceeds underweight among women in most developing countries. , 2005, The American journal of clinical nutrition.
[33] S. Yusuf,et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.
[34] M. Nsour,et al. Prevalence and predictors of nonfatal myocardial infarction in Jordan. , 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[35] E. Feskens,et al. Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey , 1996, BMJ.
[36] N. Freemantle,et al. Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. , 2004, Family practice.
[37] Paul M. Ridker,et al. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women , 2007 .
[38] A. Soltanian,et al. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. , 2007, International journal of cardiology.
[39] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.
[40] J. Tuomilehto,et al. Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[41] Dong Yaping. Community health services in China: the experience of Tianjin City. , 2001 .
[42] A. Coale,et al. The demographic transition. , 1984, Pakistan development review.
[43] Stanton A. Glantz,et al. Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking , 2005, Circulation.
[44] J. Pell,et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. , 2008, The New England journal of medicine.
[45] Adam A. Leive,et al. Financing global health: mission unaccomplished. , 2007, Health affairs.
[46] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[47] A. Rodgers,et al. Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.
[48] Giuseppe Mancia,et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. , 2007, Journal of hypertension.
[49] S. Yusuf,et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.
[50] R. Collins,et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[51] R. Califf,et al. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. , 2000, European heart journal.
[52] S. Mauss,et al. Lipoprotein(a) in patients initiating antiretroviral therapy , 2008, HIV medicine.
[53] R. Bhopal,et al. Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease , 2005, Heart.
[54] Li-sheng Liu. Cardiovascular diseases in China. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[55] Colin Mathers,et al. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors , 2006 .
[56] Jing Liu,et al. Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.
[57] M. Gertler,et al. Ischemic Heart Disease: Insulin, Carbohydrate, and Lipid Interrelationships , 1972, Circulation.
[58] Jayanti Mukherjee,et al. Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. , 2005, The American journal of cardiology.
[59] X. Zhang,et al. Coronary heart disease in China , 2008, Heart.
[60] G. Guindon,et al. Tobacco control country profiles , 2003 .
[61] S. Yusuf,et al. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.
[62] Yang-feng Wu,et al. Effect of Xuezhikang on Cardiovascular Events and Mortality in Elderly Patients with a History of Myocardial Infarction: A Subgroup Analysis of Elderly Subjects from the China Coronary Secondary Prevention Study , 2007, Journal of the American Geriatrics Society.
[63] Murilo Foppa,et al. Impacto econômico dos casos de doença cardiovascular grave no Brasil: uma estimativa baseada em dados secundários , 2008 .
[64] R. Collins,et al. Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.
[65] G Premalatha,et al. Coronary Artery Disease Prevalence of Coronary Artery Disease and Its Relationship to Lipids in a Selected Population in South India The Chennai Urban Population Study (CUPS No. 5) , 2001 .
[66] S. Leeder,et al. Coronary heart disease epidemics: not all the same , 2008, Heart.
[67] A. Barcelo,et al. The cost of diabetes in Latin America and the Caribbean. , 2003, Bulletin of the World Health Organization.
[68] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[69] V. Feigin,et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region , 2007, Journal of hypertension.
[70] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[71] T. Gaziano,et al. Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.
[72] E. Vartiainen,et al. Changes in blood pressure, body mass index, and salt consumption in a Chinese population. , 1999, Preventive medicine.
[73] Parvez Hossain,et al. Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.
[74] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[75] Ling Liu,et al. Xuezhikang, An Extract of Cholestin, Reduces Cardiovascular Events in Type 2 Diabetes Patients With Coronary Heart Disease: Subgroup Analysis of Patients With Type 2 Diabetes From China Coronary Secondary Prevention Study (CCSPS) , 2007, Journal of cardiovascular pharmacology.
[76] G. Balbinotto Neto,et al. The costs of cardiovascular disease in Brazil: a brief economic comment. , 2008, Arquivos brasileiros de cardiologia.
[77] E. Negri,et al. Trends in mortality from major diseases in Europe, 1980–1993 , 2004, European Journal of Epidemiology.
[78] Walter Willett,et al. Changes in dietary fat and declining coronary heart disease in Poland: population based study , 2005, BMJ : British Medical Journal.
[79] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[80] T. Jafar,et al. Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men , 2007, Heart.
[81] K. Reynolds,et al. Global burden of obesity in 2005 and projections to 2030 , 2008, International Journal of Obesity.
[82] L. Liu. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. , 2001, Chinese Medical Journal.
[83] Anoop Misra,et al. Obesity and the metabolic syndrome in developing countries. , 2008, The Journal of clinical endocrinology and metabolism.
[84] S. Leeder,et al. Obesity and cardiovascular disease in developing countries: a growing problem and an economic threat , 2006, Current opinion in clinical nutrition and metabolic care.
[85] J. Mackay,et al. The Tobacco Atlas , 2002 .
[86] S. Yusuf,et al. Global burden of cardiovascular disease , 2007, Heart.
[87] Milton C Weinstein,et al. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.
[88] C. Cannon,et al. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16. , 2005, International journal of cardiology.
[89] R. Horton,et al. Scaling up interventions for chronic disease prevention: the evidence , 2007, The Lancet.
[90] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[91] G. Mensah. Ischaemic heart disease in Africa , 2008, Heart.
[92] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[93] J. Ware. The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.
[94] R. Collins,et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom , 1995 .
[95] Garrett Fitzmaurice,et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort , 2008, The Lancet.
[96] A. Leiman,et al. The direct and indirect costs of cardiovascular disease in South Africa in 1991. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[97] D. Jamison,et al. Tobacco Addiction -- Disease Control Priorities in Developing Countries , 2006 .
[98] S. Mohiuddin,et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. , 2007, Chest.
[99] S. Yusuf,et al. The burden of cardiovascular disease in the Indian subcontinent. , 2006, The Indian journal of medical research.
[100] J. Powles,et al. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991 , 1998, BMJ.
[101] M. Geraedts,et al. Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study , 2009, BMC health services research.
[102] R. Collins,et al. Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. , 1995, BMJ.
[103] K. Reddy,et al. Burden of non-communicable diseases in South Asia , 2004, BMJ : British Medical Journal.
[104] C. Murray,et al. Household catastrophic health expenditure: a multicountry analysis , 2003, The Lancet.
[105] M. Khalil,et al. Coronary artery disease in Saudi Arabia. , 2004, Saudi medical journal.
[106] Salvatore Panico,et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. , 2005, International journal of epidemiology.
[107] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .